AIMD vs NNOX

For growth investors, Nano-X Imaging Ltd.

(NNOX) is the stronger pick with 13. 9% revenue growth year-over-year, versus -83. 0% for Ainos, Inc. (AIMD). Analysts rate Nano-X Imaging Ltd. (NNOX) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Nano-X Imaging Ltd.

(NNOX) delivered a total return of -93. 9%, compared to -99. 4% for Ainos, Inc. (AIMD). Over 10 years, the gap is even starker: NNOX returned -96. 1% versus AIMD's -97. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Nano-X Imaging Ltd.

(NNOX) is the lower-risk stock at 1. 86β versus Ainos, Inc. 's 2. 54β — meaning AIMD is approximately 37% more volatile than NNOX relative to the S&P 500. On balance sheet safety, Nano-X Imaging Ltd. (NNOX) carries a lower debt/equity ratio of 4% versus 77% for Ainos, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Nano-X Imaging Ltd.

(NNOX) is pulling ahead at 13. 9% versus -83. 0% for Ainos, Inc. (AIMD). On earnings-per-share growth, the picture is similar: Ainos, Inc. grew EPS 53. 6% year-over-year, compared to 15. 7% for Nano-X Imaging Ltd.. Over a 3-year CAGR, NNOX leads at 105. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Nano-X Imaging Ltd.

(NNOX) is the more profitable company, earning -474. 3% net margin versus -717. 0% for Ainos, Inc. — meaning it keeps -474. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NNOX leads at -502. 9% versus -667. 7% for AIMD. At the gross margin level — before operating expenses — NNOX leads at -94. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Nano-X Imaging Ltd.

(NNOX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Ainos, Inc. (AIMD) carries a higher beta of 2. 54 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NNOX: -96. 1%, AIMD: -97. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.